China Universal Asset Management Co. Ltd. Has $3.42 Million Stock Holdings in Lam Research Corporation $LRCX

China Universal Asset Management Co. Ltd. trimmed its position in Lam Research Corporation (NASDAQ:LRCX) by 29.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 35,042 shares of the semiconductor company’s stock after selling 14,463 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Lam Research were worth $3,417,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Sava Infond d.o.o. raised its holdings in Lam Research by 3.1% during the 2nd quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock worth $7,325,000 after purchasing an additional 2,250 shares during the last quarter. Horizon Bancorp Inc. IN bought a new stake in shares of Lam Research during the second quarter worth approximately $389,000. Empowered Funds LLC lifted its holdings in Lam Research by 10.5% in the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock valued at $13,629,000 after buying an additional 17,833 shares during the period. Genus Capital Management Inc. bought a new position in Lam Research in the second quarter valued at approximately $14,476,000. Finally, Glass Wealth Management Co LLC grew its holdings in Lam Research by 8.5% during the 2nd quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after acquiring an additional 2,270 shares during the period. 84.61% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on LRCX. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a research report on Monday, December 8th. Mizuho boosted their target price on Lam Research from $162.00 to $170.00 and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. TD Cowen increased their price target on shares of Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Berenberg Bank boosted their price objective on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Barclays set a $142.00 target price on shares of Lam Research and gave the stock an “equal weight” rating in a report on Monday, October 20th. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $152.87.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $160.52 on Friday. The company has a fifty day moving average price of $152.53 and a 200 day moving average price of $120.24. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $169.69. The firm has a market cap of $201.62 billion, a PE ratio of 35.36, a PEG ratio of 1.65 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter in the previous year, the business posted $0.86 EPS. The business’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s dividend payout ratio is 22.91%.

Insider Buying and Selling

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $157.47, for a total value of $1,418,804.70. Following the sale, the insider owned 56,786 shares in the company, valued at approximately $8,942,091.42. This represents a 13.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 102,608 shares of company stock valued at $14,916,496 in the last ninety days. 0.31% of the stock is owned by company insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.